IP Library Granted Patent US 11,180,464
Granted Patent B2
US 11,180,464 · App. 16/751,811 · Granted Nov 23, 2021

Phenothiazine diaminium salts and their use

Inventors: Colin Marshall (Old Aberdeen, GB); Scott Clunas (Old Aberdeen, GB); John Mervyn David Storey (Aberdeen, GB); James Peter Sinclair (Old Aberdeen, GB); Thomas Craven Baddeley (Old Aberdeen, GB); Ahtsham Ishaq (Old Aberdeen, GB); Michael Simpson (Old Aberdeen, GB); Craig Williamson (Guildford, GB); Barry Alan Wood (Old Aberdeen, GB); Claude Michel Wischik (Aberdeen, GB); Charles Robert Harrington (Aberdeen, GB); Janet Elizabeth Rickard (Aberdeen, GB); David Horsley (Aberdeen, GB); Yin Sze Loh (Singapore, SG); Karrar Ahmad Khan (West Bridgeford, GB); Christopher Paul Larch (Old Aberdeen, GB)
Assignee: WisTa Laboratories Ltd.
C07D279/20A61K9/0053A61K9/2095A61K31/5415A61L2/0052A61P31/04A61P31/12A61P31/14A61P31/18A61P33/02A61P33/06A61P35/00A61K9/2893C07C303/32C07C309/04C07C309/05C07C309/30C07C309/35Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,180,464
App. No.
16/751,811
Granted
Nov 23, 2021
Kind
B2
Abstract

Disclosed are compounds of general formula (I): and pharmaceutically acceptable salts thereof, formulations, methods and uses in, for example, the treatment of disease.

Claims (3)

1. A compound of the following formula:

or a pharmaceutically acceptable salt, solvate, or hydrate thereof.

2. The compound according to claim 1 in crystalline form, having a crystal structure as represented by FIGS. 11-16 .

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2021
From: MARSHALL, COLIN; CLUNAS, SCOTT; STOREY, JOHN MERVYN DAVID; SINCLAIR, JAMES PETER; BADDELEY, THOMAS CRAVEN; ISHAQ, AHTSHAM; SIMPSON, MICHAEL; WILLIAMSON, CRAIG; WOOD, BARRY ALAN; WISCHIK, CLAUDE MICHEL; HARRINGTON, CHARLES ROBERT; RICKARD, JANET ELIZABETH; HORSLEY, DAVID
To: WISTA LABORATORIES LTD.
Reel/Frame 056741/0177 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2021
From: LOH, YIN SZE
To: WISTA LABORATORIES LTD.
Reel/Frame 056741/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2021
From: KHAN, KARRAR AHMAD
To: WISTA LABORATORIES LTD.
Reel/Frame 056741/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2021
From: LARCH, CHRISTOPHER PAUL
To: WISTA LABORATORIES LTD.
Reel/Frame 056730/0235 →
Priority Claims (1)
SG 201101060-0 · Feb 11, 2011 · national
Continuity (5)
Division 15912166 · Mar 5, 2018
Division 15056610 · Feb 29, 2016
Division 13984841
Provisional Application 61485880 · May 13, 2011
Related Publication 20200246350A1 · Aug 6, 2020
Cited By (2)
US 12,263,175 US 12,324,810